Natural History of Stargardt Disease: The Longest Follow-Up Cohort Study.

DDAF area ERG groups Fishman stages STGD1 genotype-phenotype correlations long-term follow-up

Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
02 07 2023
Historique:
received: 11 06 2023
revised: 30 06 2023
accepted: 30 06 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Long-term natural history studies are important in rare disease research. This study aimed to assess electrophysiological and fundus autofluorescence (FAF) progression rate in 18 genetically confirmed Stargardt disease (STGD1) patients with a minimum follow-up of 10 years. Age at the first and last exams, age at onset, Snellen decimal visual acuity (VA), electroretinography (ERG), and FAF images were evaluated. Patients were classified into four Fishman stages and three electroretinography groups, and areas of definitely decreased autofluorescence (DDAF) were measured. Patients were further substratified based on genotype, and phenotype-genotype correlations were performed. The median follow-up was 18 (range 10-26) years. The median yearly VA loss was 0.009 (range 0.002-0.071), while the median progression rate of the DDAF area was 0.354 (range 0.002-4.359) mm

Identifiants

pubmed: 37510299
pii: genes14071394
doi: 10.3390/genes14071394
pmc: PMC10379489
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Ophthalmology. 2019 Dec;126(12):1712-1721
pubmed: 31522899
Exp Eye Res. 2009 Jun 15;89(1):16-24
pubmed: 19217903
PLoS One. 2022 Dec 9;17(12):e0278857
pubmed: 36490268
Ophthalmology. 2003 Jun;110(6):1151-8
pubmed: 12799240
Am J Ophthalmol. 2020 Mar;211:159-175
pubmed: 31812472
Am J Ophthalmol. 2012 Jul;154(1):146-54
pubmed: 22464366
Doc Ophthalmol. 2013 Feb;126(1):1-7
pubmed: 23073702
Am J Ophthalmol. 2015 May;159(5):964-72.e2
pubmed: 25681002
Transl Vis Sci Technol. 2021 Jan 05;10(1):3
pubmed: 33505770
Ophthalmology. 2016 Apr;123(4):817-28
pubmed: 26786511
Arch Ophthalmol. 1976 Dec;94(12):2061-7
pubmed: 999551
Doc Ophthalmol. 1992;81(2):253-9
pubmed: 1468355
Ophthalmology. 2015 Feb;122(2):326-34
pubmed: 25312043
Eur J Hum Genet. 2020 Jul;28(7):925-937
pubmed: 32467599
Ophthalmology. 2014 Dec;121(12):2399-405
pubmed: 25097154
Genet Med. 2020 Jul;22(7):1235-1246
pubmed: 32307445
Invest Ophthalmol Vis Sci. 2014 Oct 16;55(11):7467-78
pubmed: 25324290
Mol Vis. 2012;18:227-33
pubmed: 22312191
Invest Ophthalmol Vis Sci. 2013 Dec 17;54(13):8181-90
pubmed: 24265018
Int J Mol Sci. 2022 Dec 18;23(24):
pubmed: 36555803
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5186-5191
pubmed: 27699414
JAMA Ophthalmol. 2017 Jul 1;135(7):687-695
pubmed: 28542697
Invest Ophthalmol Vis Sci. 2012 Jul 03;53(8):4458-67
pubmed: 22661473
Doc Ophthalmol. 2022 Jun;144(3):165-177
pubmed: 35511377
Invest Ophthalmol Vis Sci. 2022 May 2;63(5):28
pubmed: 35608843
Br J Ophthalmol. 2009 Dec;93(12):1600-5
pubmed: 19628494
J Med Genet. 2017 Jun;54(6):404-412
pubmed: 28446513
Am J Ophthalmol. 2013 Jun;155(6):1075-1088.e13
pubmed: 23499370
Invest Ophthalmol Vis Sci. 2013 Sep 27;54(9):6416-25
pubmed: 23882696
BMC Ophthalmol. 2016 Jan 22;16:13
pubmed: 26801981
JAMA Ophthalmol. 2019 Oct 01;137(10):1134-1145
pubmed: 31369039
Ophthalmology. 2015 Feb;122(2):335-44
pubmed: 25444351
Prog Retin Eye Res. 2020 Nov;79:100861
pubmed: 32278709
Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5946-55
pubmed: 26377081
Sci Rep. 2023 Jun 9;13(1):9380
pubmed: 37296172
Exp Eye Res. 2010 Aug;91(2):143-52
pubmed: 20398653
Transl Vis Sci Technol. 2020 Jun 25;9(7):33
pubmed: 32832238
Ophthalmol Clin North Am. 2002 Mar;15(1):93-100, viii
pubmed: 12064087
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3220-3231
pubmed: 29971439
Hum Mutat. 2003 Nov;22(5):395-403
pubmed: 14517951
Arch Ophthalmol. 2001 Mar;119(3):359-69
pubmed: 11231769
Hum Mol Genet. 2021 Jun 26;30(14):1293-1304
pubmed: 33909047
Arch Ophthalmol. 2012 Feb;130(2):171-9
pubmed: 21987580
Ophthalmology. 2016 Sep;123(9):1887-97
pubmed: 27378015
Br J Ophthalmol. 2017 Jan;101(1):25-30
pubmed: 27491360
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2668-75
pubmed: 10509664
Invest Ophthalmol Vis Sci. 2016 Nov 01;57(14):5963-5973
pubmed: 27820952
Ophthalmic Genet. 2011 Sep;32(3):165-74
pubmed: 21510770
PLoS One. 2017 Mar 29;12(3):e0174020
pubmed: 28355279
PLoS Genet. 2022 Mar 30;18(3):e1010129
pubmed: 35353811
JAMA Ophthalmol. 2017 Nov 1;135(11):1232-1241
pubmed: 29049437
Cell. 1999 Jul 9;98(1):13-23
pubmed: 10412977
Retina. 2022 Aug 1;42(8):1545-1559
pubmed: 35344533
Am J Ophthalmol. 2023 Jun;250:157-170
pubmed: 36764427

Auteurs

Jana Sajovic (J)

Eye Hospital, University Medical Centre Ljubljana, Grablovičeva ulica 46, 1000 Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.

Andrej Meglič (A)

Eye Hospital, University Medical Centre Ljubljana, Grablovičeva ulica 46, 1000 Ljubljana, Slovenia.

Ana Fakin (A)

Eye Hospital, University Medical Centre Ljubljana, Grablovičeva ulica 46, 1000 Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.

Jelka Brecelj (J)

Eye Hospital, University Medical Centre Ljubljana, Grablovičeva ulica 46, 1000 Ljubljana, Slovenia.

Maja Šuštar Habjan (M)

Eye Hospital, University Medical Centre Ljubljana, Grablovičeva ulica 46, 1000 Ljubljana, Slovenia.

Marko Hawlina (M)

Eye Hospital, University Medical Centre Ljubljana, Grablovičeva ulica 46, 1000 Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.

Martina Jarc Vidmar (M)

Eye Hospital, University Medical Centre Ljubljana, Grablovičeva ulica 46, 1000 Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH